Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAV2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC7A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEPTOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UGGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SC5D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM107B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDFIC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927420 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ND6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM102B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBLCP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NT5E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
N4BP2L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBPL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASNS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SHMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on